Biotechnology Labels and Packaging Market Size & Innovations

Biotechnology Labels and Packaging Market Size to Rise in Coming Years

From 2023 to 2034, the global biotechnology labels and packaging market is set for a massive revenue upswing, with projections of growth reaching hundreds of millions of dollars.

Biotechnology Labels and Packaging Market Size and Global Growth Insight

The global biotechnology labels and packaging market size is accelerating, with forecasts predicting hundreds of millions in revenue growth between 2023 and 2034, powering sustainable infrastructure globally.

The biotechnology labels and packaging market is expected to witness considerable growth during the forecast period. Labeling and packaging is very significant factor in the biotechnology sector. End users depend on these labels to recognize as well as understand important information. The health of the consumers is greatly impacted by biotech products, thus it's necessary to give precise information on usage guidelines, date of expiration and ingredient lists. Customers can feel secure knowing that the products they get are safe for consumption and fresh due to the tamper-evident labeling and protective packaging.

The expansion of the biotechnology and pharmaceutical industries along with the rise of personalized medicine is expected to augment the growth of the biotechnology labels and packaging market during the forecast period. Furthermore, the increasing regulatory pressure from the bodies like the FDA and EMA is pushing companies to invest in high-quality labeling to maintain the compliance and prevent counterfeiting which is also anticipated to augment the growth of the market. Additionally, the rapid growth in the production of vaccines, diagnostics and biologics along with the growing need for sterile, temperature-controlled and moisture-resistant packaging are also projected to contribute to the growth of the market in the years to come.

Key Trends and Findings

  • In the years to come, biotech is expected to gain more attention and support as a means of maintaining enough production in the midst of the shifting global standards and regulations regarding the utilization of land, water and carbon emissions. Certain biotech solutions may have advantages in global or regional regulations, norms, or markets if policies evolve which support environmentally limited or carbon-neutral technologies.
  • By 2040, it is expected that the automation and data-driven operations being progressively integrated into biotechnology would have significantly increased the predictability and accuracy of research and industrial results. The integration of digital and biological technologies is likely to accelerate as automated molecular assembly approaches involving DNA and other biomolecules push design and engineering capabilities into nano-scale application domain.
  • Due to a wide range of biotech developments such as disease vector control and the invention of new treatments and preventive medicines, it may be possible to completely eliminate the most common diseases within the next 20 years. However, due to unequal global access to these technologies over this time, real-world execution is not expected to correspond with the theoretical health potential.
  • At the moment, one of the main subjects of the biotech research is cellular anti-aging. Scientists think that it is possible to actually reverse the aging process that could help people live longer as well as possibly lead to the development of therapies or cures for conditions that are currently incurable. Another biotech development is CRISPR-based gene editing. This modern technology provides accurate alterations to DNA, suggesting possible therapies for hereditary illnesses.
  • North America held largest market share in 2023. This is due to the strong presence of the biotechnology and pharmaceutical industries, stringent regulatory requirements and the increasing focusing on sustainable and smart packaging solutions.
  • Asia-Pacific is expected to grow at a fastest CAGR during the forecast period owing to the increasing healthcare investments and biotechnological advancements along with the expanding pharmaceutical production as well as the growing export activities.

Market Drivers

Growing Biotechnology Sector

The rising biotechnology sector is expected to fuel the growth of the biotechnology labels and packaging market within the estimated timeframe. It is expected that biotechnology will find many applications over the next two decades. Through the development of the personalized medications, personalized treatment plans, precise diagnostics as well as preventive healthcare, biotechnology has completely altered the medicine. This biotechnology revolution in medicine has been sparked by important discoveries such as genetic engineering, monoclonal antibodies, recombinant DNA technology, polymerase chain reaction, DNA sequencing and stem cell therapies. Biotechnology has impacted every aspect of medicine, from gene therapy to pharmacogenomics, biopharmaceuticals and prenatal testing, improving patient quality of life, treatment outcomes, and disease management all while reducing the healthcare costs.

Along with healthcare, biotechnology provides huge potential for the agriculture sector as well. Biotechnology gives farmers technologies that can help them produce more cheaply and efficiently. For instance, certain biotechnology crops can be modified to withstand particular herbicides, simplifying and improving weed control. Apart from crops that have been genetically modified, biotechnology has contributed to various advancements in the agriculture that do not include plants. Some examples of these developments are the use of microbial fermentation to increase the efficiency of the antibiotic manufacture and the utilization of genetic engineering to create novel animal vaccinations against diseases like rabies and disease of the foot and mouth.

Furthermore, the global expansion of the biotechnology sector is also fueled due to the increasing investments in research and development in genomics, proteomics and biomanufacturing. For instance, in December 2023, Adcentrx Therapeutics declared that its Series A+ funding had been extended. The $38 million Series A+ that was concluded in April 2023 is now strengthened by the extra $13 million. With the backing of new financing, the firm is concentrating on speeding up the clinical research of ADRX-0706 as well as the development of additional pipeline items into the clinic. As the biotechnology industry continues to innovate and expand globally, particularly in areas such as personalized medicine and complex drug formulations, the demand for advanced, compliant and protective packaging options will increase, making it a significant market driver.

Market Restraints

Cold Chain Management and Regulatory Complexities in Biotechnology Packaging

The cold chain management and regulatory complexities in biotechnology packaging is likely to hinder the growth of the market within the estimated timeframe. Biotechnology products such as cell or gene therapy and biologics, can have complex labeling, packaging and distribution processes. For many of these medications, preserving the integrity and effectiveness of the drug product (DP) along the supply chain demands cryogenic (-40 °C and below) and cold chain (2-8 °C) storage, creating numerous challenges. Some of the challenges faced by packaging and labeling professionals working with these products include deciding when to utilize glass or plastic containers for the primary package, retaining label integrity in cryogenic conditions, regulatory visual and labeling market requirements, substantially smaller batch sizes than DP made in tablet form as well as logistics for transportation and protection in the cold chain and cryogenic environments.

Furthermore, specific delivery methods like prefilled syringes, auto-injectors and other equipment will be needed for some of these treatments. The process becomes more complicated since the graphics and packaging for these therapies must strictly comply with the regulatory framework for combination products. Additionally, the packaging of biologics presents particular difficulties such as process inspections and refrigeration time. Biologics become more expensive when equipment breaks down or is discovered to be malfunctioning as they must be stored in refrigeration and can only be kept outside of such temperatures for a limited period of time. In this case, the majority of the time the drugs are no longer useful, and it is also more expensive to perform destructive testing on biologics. Also, highly engineered and personalized biologics for rare diseases pose another obstacle for manufacturers of packaging and this is further expected to restrict the market growth within the estimated timeframe.

Market Opportunities

Rising Demand for Biologics

Biologics are in greater demand due to their capacity to address the root causes of disease, beneficial safety data and successful clinical outcomes. Biologics have advanced rapidly due to the advancements in proteins, nucleic acids, peptides, vaccinations, and monoclonal antibodies (mAbs), particularly in recent years. Approximately 671 biologics products had FDA approvals as of April 2023. Numerous diseases such as arthritis, cancer, kidney disease, diabetes, macular degeneration and skin disorders like ulcerative colitis, Crohn's disease and psoriasis, are treated with biologics.  Furthermore, there is increasing investment in the expansion of biologics manufacturing capacities which is also expected to support the market growth in future. For instance:

  • In September 2024, Eli Lilly and Company revealed that it will be investing an additional $1 billion to expand its manufacturing facility in Ireland, and improve the manufacturing of biologic active ingredients. The expansion of production comprises biologic active components for Lilly's Kisunla (donanemab-azbt) that received FDA approval in July 2024 to treat initial symptomatic Alzheimer's disease. Simultaneously, the business disclosed an $800 million for the expansion of its facility in Kinsale, Ireland, which will be used to develop Lilly's most recent obesity and diabetes therapies due to market demand.
  • In August 2024, AstraZeneca revealed the most significant single investment in its Sweden Biomanufacturing Centre since it launched in 2021. The biopharmaceutical facility's area will expand by 50% with the new $135 million investment. According to the corporation, the Sweden Biomanufacturing Center uses modern technologies in order to meet the demands of expanding internal production capacity and the steadily increasing market share of biological medicines.
  • In January 2024, AbbVie announced its latest US$223 million expansion of its production facility in Singapore, augmenting its manufacturing capabilities. This additional investment will support AbbVie's pipeline of upcoming immunology and oncology compounds in addition to current pharmaceuticals by adding 24,000 liters of biological products drug-substance capacity to the company's worldwide production network.

This increase in demand as well as the rise in biologics production and adoption, creates numerous opportunities for the packaging manufacturers to develop solutions that not only maintain the product effectiveness but also guarantees compliance with increasingly complex regulations, all while improving product safety and sustainability throughout the supply chain.

Key Segment Analysis

Product Type Segment Analysis Preview

The packaging segment held considerable market share in 2023. The increasing demand for biologics, gene therapies and vaccines is expected to support the segmental growth of the market. This is owing to the rising prevalence of chronic diseases such as cancer, autoimmune disorders and diabetes along with the shift towards personalized medicine. Furthermore, the growing demand for maintaining the right temperature range during transportation and  compliance to the strict guidelines such as current Good Manufacturing Practices, requiring certifications from EMA (European Medicines Agency), FDA (Food and Drug Administration) is also expected to contribute to the growth of the segment during the forecast period. Additionally, in an effort to minimize waste during the packaging process, packaging firms like Single Use Support are developing creative solutions like multi-use shells for the single-use bags which is further anticipated to fuel the segmental growth in the years to come.

End-User Segment Analysis Preview

The biotechnology companies segment held the largest market share in 2023. The rapid expansion of biopharmaceutical research and development and the rising incidence of various diseases like cancer, autoimmune disorders and rare genetic conditions are anticipated to accelerate the segmental growth of the market. Additionally, the growing focus on precision medicine combined with the surge in vaccine production and biologic drug development is further projected to contribute the growth of the segment in the global market. Also, the significant investments in R&D globally as well as the rising trend of collaboration between biotechnology firms and pharmaceutical companies are further likely to fuel the segment's growth in the near future.

Regional Insights

North America held the largest market share in the world in 2023. This is due to the presence of large number of biotechnology and pharmaceutical companies such as Amgen, Gilead Sciences, Pfizer and Biogen, among others that are at the forefront of innovation in biologics. Furthermore, the rising demand for biologics and advanced therapies and a well-established healthcare infrastructure is also expected to contribute to the regional growth of the market. Additionally, the increase in funding for biotechnology research and development from the U.S. and Canadian governments to support innovation in the biopharmaceuticals and gene therapies is projected to fuel the growth of the market in the region in the years to come.

Asia Pacific is likely to grow at fastest CAGR during the forecast period. This is owing to the rapid growth of biotechnology and pharmaceutical sectors in countries like China, India and Japan. According to the data by the India Brand Equity Foundation, by 2025, the biotechnology sector in India is projected to be valued at US$ 150 billion, and by 2030, it is likely grow to reach US$ 270–300 billion. It is projected that the Indian biotechnology sector will account for 19% of the worldwide biotechnology market by 2025. Furthermore, the rising focus on improving healthcare systems and the government initiatives and investment in biotechnology are also expected to support the regional growth of the market. Additionally, the increase in healthcare expenditure as well as a large potential for clinical research applications is also anticipated to promote the growth of the market in the region in the near future.

Recent Developments by Key Market Players

  • In June 2024: Sharp declared intentions to grow its sterile injectables packaging production capacity by expanding its Macungie, Pennsylvania facility in North America. For pharmaceutical and biotech firms, the expansion will provide improved capacity for secondary packaging activities such as Pre-Filled Syringe (PFS) assembly and labeling, Vial Labeling, Autoinjector/Pen assembly and labeling and Injectables Kitting and Cartoning.
  • In March 2024: SCHOTT Pharma disclosed plans to develop its first plant in the United States for making prefillable polymer syringes required for deep-cold storage and shipping of mRNA therapeutics. Furthermore, the facility will be able to manufacture glass prefillable syringes for GLP-1 therapy, which could be used to treat conditions like obesity or diabetes. With a $371 million total investment, the project is anticipated to complete by the end of 2024 and begin operations in 2027.

Key Market Players

Some of the key players in biotechnology labels and packaging market West Pharmaceutical Services, Inc., CCL Healthcare, Aphena Pharma Solutions, RLG Healthcare, SCHOTT Pharma, ATL Corp., NADCO® Tapes & Labels, Inc., Intelsius, Earthwise Packaging, BellatRx Inc., and Sharp Services, LLC.,  among others.

Biotechnology Labels and Packaging Market Segments

By Product Type

  • Labels
    • RFID Labels
    • Tamper-Evident Labels
    • Temperature-Sensitive Labels
    • Smart Labels
    • Others
  • Packaging
    • Vials & Ampoules
    • Prefilled Syringes
    • Cartridges
    • Cold Chain Storage
    • Others

By Material

  • Plastics
  • Glass
  • Paper & Paperboard
  • Others

By End-User

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Others

By Region

  • North America
    • U.S.
    • Canada
  • Mexico
    • Europe
    • U.K.
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-East Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
Share With : linkedin twitter facebook
  • Insight Code: 5309
  • No. of Pages: 150
  • Format: PDF/PPT/Excel
  • Published: October 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

Meet the Team

Rohan Patil is a market research expert with 3+ years of experience in healthcare packaging, specializing in advanced materials, regulatory compliance, sustainability, and innovative packaging technologies to enhance product safety and efficiency.

Learn more about Rohan Patil

Aditi Shivarkar, with 14+ years in packaging market research, specializes in food, beverage, and eco-friendly packaging. She ensures accurate, actionable insights, driving Towards Packaging 's excellence in industry trends and sustainability.

Learn more about Aditi Shivarkar

Related Insights

FAQ's

North America region leads the global biotechnology labels and packaging market.

West Pharmaceutical Services, Inc., CCL Healthcare, Aphena Pharma Solutions, RLG Healthcare, SCHOTT Pharma, ATL Corp., NADCO® Tapes & Labels, Inc., Intelsius, Earthwise Packaging, BellatRx Inc., and Sharp Services, LLC.,  among others are the prominent players operating in the biotechnology labels and packaging market.